Delivery Order SPE2DB24D1107-SPE2DB26FZDJ7
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Primaquine 26.3 mg tablets (100-count units) valued at $1,373.34. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and carries an ultimate completion date of September 19, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this order. The delivery order represents a child contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,633.04 firm fixed-price delivery order for Primaquine 26.3 mg tablets (100-count units) with an ultimate completion date of June 5, 2025. This non-set-aside contract represents a child order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Primaquine 26.3 mg tablets (100-count units) with a contract value of $1,713.32. This is a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The Defense Logistics Agency awarded a delivery order valued at $1,461.74 to AmerisourceBergen Drug Corp for Primaquine 26.3 mg tablets (100-count) on June 16, 2025, with completion scheduled for June 17, 2025. This is a firm fixed-price, non-set-aside delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026. AmerisourceBergen,...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of Primaquine 26.3 mg tablets in a quantity of 100 units, valued at $1,816.32 with a firm fixed price structure. This award represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of July 16, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $3,669.16 to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Primaquine 26.3 mg tablets (100-count units). The contract utilizes firm fixed pricing under a non-set-aside competitive procurement and is scheduled for completion by September 16, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a leading pharmaceutical distributor and critical federal vendor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Primaquine 26.3 mg tablets (100-count units) valued at $2,645.98 with an ultimate completion date of August 21, 2025. This is a firm fixed price, competitively awarded delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a $2,807.27 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Primaquine 26.3 mg tablets (100-count units). The contract utilizes firm fixed pricing with an ultimate completion date of July 21, 2025, and represents a non-set-aside, competitively awarded procurement. Performance will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 29, 2025, for the supply of Primaquine 26.3 mg tablets in a quantity of 100 units, with a contract ceiling value of $1,231.50. This firm fixed-price delivery order, which is not set-aside designated, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The contract is scheduled for ultimate completion by May 30, 2025, with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Primaquine 26.3 mg tablets (100-count units) under a firm fixed-price contract. The contract has a ceiling value of $3,419.98 and an ultimate completion date of August 25, 2025. This award is unset-aside and was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB24D1107Indefinite Delivery Contract
- SPE2DB24D1107-SPE2DB26FZDJ7Delivery Order
The Defense Logistics Agency awarded a $1,513.54 delivery order to AmerisourceBergen Drug Corp on October 8, 2025, for the supply of Primaquine 26.3 mg tablets (100-count units). This is a firm fixed-price, non-set-aside contract with performance in Conshohocken, Pennsylvania, scheduled for completion by October 9, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, maintains an extensive portfolio of federal medical procurement contracts primarily with the Defense Logistics Agency and its Medical Supply Chain. The company's federal contracting demonstrates capability across diverse pharmaceutical products including specialty medications, generic drugs, vaccines, and medical supplies. This particular award for antimalarial medication supports the broader Defense Health Agency mission to supply critical pharmaceuticals to military personnel and veterans through a competitively awarded, firm fixed-price arrangement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 10/8/25 |